This site is intended for healthcare professionals

Specialty hub

Neurology (CNS) and Pain

Containing dedicated Learning Zones, guidelines, trials and news for related conditions in Neurology (CNS) and Pain.

Read time: 5 mins

Last updated: 28th Sep 2020

Welcome:

Sign in/Register

Updates in your area
of interest

Articles your peers
are looking at

Bookmarks
saved

Days to your
next event

Neurology is the branch of medicine that deals with conditions and diseases involving the central nervous system (brain and spinal cord) and the peripheral nervous systems (autonomic and somatic), including their coverings, blood vessels, and all effector tissue such as muscle.

Neurology encompasses over 5000 neurological diseases and relies on insights from fields such as neuroscience. This medical speciality deals with dementia including Alzheimer’s disease, Parkinson’s disease, neuromuscular disorders including spinal muscular atrophy and pain management as a sub-speciality.

EAN 2020 Congress Highlights: MS Looking Forward

Explore expert led content from the Biogen satellite symposium! Discover how digital tools are accelerating the collection of big data and learn how innovative new research can allow healthcare professionals to tailor natalizumab treatment.

View video presentations

Diseases in this section

Attention Deficit Hyperactivity Disorder (ADHD)

Containing relevant Learning Zones, guidelines, trials and news.

Dementia

Containing relevant Learning Zones, guidelines, trials and news.

Epilepsy

Containing relevant Learning Zones, guidelines, trials and news.

Neuromuscular Disorders

Containing relevant Learning Zones, guidelines, trials and news.

Pain

Containing relevant Learning Zones, guidelines, trials and news.

Parkinson's Disease

Containing relevant Learning Zones, guidelines, trials and news.

Learning Zones

Anticoagulation Therapy for Stroke Prevention

Learning Zone Homepage

Anticoagulation Therapy for Stroke Prevention

1 mins

COMT inhibition in Parkinson’s Disease

Learning Zone Homepage

COMT inhibition in Parkinson’s Disease

1 mins

Spinal Muscular Atrophy

Learning Zone Homepage

Spinal Muscular Atrophy

1 mins

Neuroscience and Pain Learning Zone

Learning Zone Homepage

Neuroscience and Pain Learning Zone

1 mins

Related news and insights

FDA issues Complete Response Letter for Libervant to treat seizure clusters.- Aquestive Therapeutics

Aquestive Therapeutics, Inc. announced that the FDA has issued a complete response letter (CRL) regarding the New Drug Application (NDA) for Libervant (diazepam) Buccal Film for management of seizure clusters.

1 mins

Novartis provides update on AVXS-101 Intrathecal Clinical Development Program for spinal muscular atrophy.

Novartis Gene Therapies recently received feedback from the FDA following their review of data from the STRONG study of the intrathecal (IT) formulation of AVXS-101 in older patients with spinal muscular atrophy (SMA).

1 min

Semorinemab,anti-Tau antibody, in early Alzheimer’s disease fails in Phase II trial.- AC Immune + Genentech Roche.

AC Immune SA announced that Genentech, a member of the Roche Group, has informed the Company of top line results from a Phase II trial of the anti-Tau antibody, semorinemab, in early (prodromal to mild) Alzheimer’s disease (AD) which show that semorinemab did not meet its primary efficacy endpoint of reducing decline on Clinical Dementia Rating-Sum of Boxes (CDR-SB) compared to placebo.

1 min

See all news

Related drugs

Pizotifen 1.5mg Tablets.

Pizotifen 1.5mg Tablets.

5 mins

Pizotifen 0.5mg Tablets

Pizotifen 0.5mg Tablets

5 mins

Levetiracetam Mylan 1000 mg film-coated tablets

Levetiracetam Mylan 1000 mg film-coated tablets

26 mins

Zebinix 800 mg tablets

Zebinix 800 mg tablets

28 mins

Rizatriptan 5 mg Orodispersible Tablets

Rizatriptan 5 mg Orodispersible Tablets

16 mins

Pregabalin Tillomed 75 mg capsules, hard

Pregabalin Tillomed 75 mg capsules, hard

21 mins

Pregabalin Tillomed 50 mg capsules, hard

Pregabalin Tillomed 50 mg capsules, hard

21 mins

Pregabalin Tillomed 300 mg capsules, hard

Pregabalin Tillomed 300 mg capsules, hard

21 mins

Pregabalin Tillomed 25 mg capsules, hard

Pregabalin Tillomed 25 mg capsules, hard

21 mins

Pregabalin Tillomed 225 mg capsules, hard

Pregabalin Tillomed 225 mg capsules, hard

21 mins

Pregabalin Tillomed 200 mg capsules, hard

Pregabalin Tillomed 200 mg capsules, hard

21 mins

Pregabalin Tillomed 150 mg capsules, hard

Pregabalin Tillomed 150 mg capsules, hard

21 mins

Pregabalin Tillomed 100 mg capsules, hard

Pregabalin Tillomed 100 mg capsules, hard

21 mins

14 mins

Ultramol Soluble

Ultramol Soluble

14 mins

Related Guidelines

Cannabis-based medicinal products

This guideline covers prescribing of cannabis-based medicinal products for people with intractable nausea and vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy.

1 mins

Risk reduction and management of delirium

This guideline provides recommendations based on current evidence for best practice in the detection, assessment, treatment and follow up of adults with delirium, as well as reducing the risk of delirium.

1 min

Pharmacological management of migraine

This guideline provides recommendations on the pharmacological management of adults with acute migraine, and prophylaxis for patients with episodic or chronic migraine or medication overuse headache.

1 min

See all guidelines

Your peers are looking at...

Johnson & Johnson posts interim results from phase 1/IIa clinical trial of JNJ-78436735 to treat COVID-19.

Johnson & Johnson posts interim results from phase 1/IIa clinical trial of JNJ-78436735 to treat COVID-19.

2 mins

EU approves Ayvakyt for metastatic gastrointestinal stromal tumors.- Blueprint Medicines Corp

EU approves Ayvakyt for metastatic gastrointestinal stromal tumors.- Blueprint Medicines Corp

1 mins

FDA issues Complete Response Letter for Libervant to treat seizure clusters.- Aquestive Therapeutics

FDA issues Complete Response Letter for Libervant to treat seizure clusters.- Aquestive Therapeutics

1 mins

Keytruda plus chemotherapy reduced risk of death by 27% versus chemotherapy as first-line treatment for locally advanced or metastatic esophageal cancer.- Merck Inc.

Keytruda plus chemotherapy reduced risk of death by 27% versus chemotherapy as first-line treatment for locally advanced or metastatic esophageal cancer.- Merck Inc.

4 mins

In an interim analysis Opdivo in CheckMate -274 met primary endpoints of disease-free survival in both all randomized patients and in patients whose tumors express PD-L1 in at least 1% of cells.- BMS

In an interim analysis Opdivo in CheckMate -274 met primary endpoints of disease-free survival in both all randomized patients and in patients whose tumors express PD-L1 in at least 1% of cells.- BMS

1 mins

Phase III TIMES 2 and 3 trials of imeglimin meet primary endpoints in type 2 diabetes.- Poxel

Phase III TIMES 2 and 3 trials of imeglimin meet primary endpoints in type 2 diabetes.- Poxel

2 mins

FDA approves Alaway to treat ocular itching.-Bausch + Lomb

FDA approves Alaway to treat ocular itching.-Bausch + Lomb

1 mins

Novavax initiates phase III efficacy trial of COVID-19 vaccine, NVX-CoV2373, in the United Kingdom.

Novavax initiates phase III efficacy trial of COVID-19 vaccine, NVX-CoV2373, in the United Kingdom.

1 mins

European Commission approves Jyseleca to treat adults with moderate to severe rheumatoid arthritis.- Gilead Sciences + Galapagos NV.

European Commission approves Jyseleca to treat adults with moderate to severe rheumatoid arthritis.- Gilead Sciences + Galapagos NV.

1 mins

FDA approves Kalydeco as first and only CFTR modulator to treat eligible infants with CF as early as four months of age.- Vertex

FDA approves Kalydeco as first and only CFTR modulator to treat eligible infants with CF as early as four months of age.- Vertex

1 mins

Related Journals

The Association Between Vitamin D Status, Vitamin D Supplementation, Sunlight Exposure, and Parkinson's Disease: A Systematic Review and Meta-Analysis.

The Association Between Vitamin D Status, Vitamin D Supplementation, Sunlight Exposure, and Parkinson's Disease: A Systematic Review and Meta-Analysis.

1 mins

Assessing pain in non-intubated critically ill patients unable to self report: an adaptation of the Behavioral Pain Scale.

Assessing pain in non-intubated critically ill patients unable to self report: an adaptation of the Behavioral Pain Scale.

1 mins

Emergency Management of Epilepsy and Seizures.

Emergency Management of Epilepsy and Seizures.

1 mins

Executive function in eating disorders: The role of state anxiety

Executive function in eating disorders: The role of state anxiety

1 mins

Alemtuzumab depletion failure can occur in multiple sclerosis.

Alemtuzumab depletion failure can occur in multiple sclerosis.

1 mins

Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage.

Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage.

1 mins

Neuropathology of Alzheimer's disease.

Neuropathology of Alzheimer's disease.

1 mins

Therapeutic Monoclonal Antibodies: What Headache Specialists Need to Know.

Therapeutic Monoclonal Antibodies: What Headache Specialists Need to Know.

1 mins

Association of White Matter Structure With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.

Association of White Matter Structure With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.

1 mins

Methylphenidate hydrochloride modified-release in adults with attention deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial.

Methylphenidate hydrochloride modified-release in adults with attention deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial.

1 mins

Related Events

BNA 2021 Festival Of Neuroscience

BNA 2021 Festival Of Neuroscience

1 mins

European Neurosurgery 2021

European Neurosurgery 2021

1 mins

World Congress for Brain Mapping and Therapeutics of SBMT 2021 (SBMT 2021)

World Congress for Brain Mapping and Therapeutics of SBMT 2021 (SBMT 2021)

1 mins

Related Clinical Trials

An Efficacy Study of Teriflunomide in Participants With Relapsing Multiple Sclerosis (TOWER)

An Efficacy Study of Teriflunomide in Participants With Relapsing Multiple Sclerosis (TOWER)

3 mins

Identification of a Biomarker Predictive of Evolution of Parkinson Disease (GLIAPARK)

Identification of a Biomarker Predictive of Evolution of Parkinson Disease (GLIAPARK)

3 mins

Efficacy and Safety of Ofatumumab Compared to Placebo in Patients With Relapsing Multiple Sclerosis Followed by Extended Treatment With Open-label Ofatumumab

Efficacy and Safety of Ofatumumab Compared to Placebo in Patients With Relapsing Multiple Sclerosis Followed by Extended Treatment With Open-label Ofatumumab

3 mins

Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults (GWPCARE3)

Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults (GWPCARE3)

4 mins

Simvastatin in Secondary Progressive Multiple Sclerosis (MS-OPT)

Simvastatin in Secondary Progressive Multiple Sclerosis (MS-OPT)

3 mins

Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects ?1 Month to <4 Years With Partial-onset Seizures

Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects ?1 Month to <4 Years With Partial-onset Seizures

3 mins

Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin (PEGASUS)

Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin (PEGASUS)

1 mins

A Safety and Efficacy Study of Oral Cladribine in Subjects With Relapsing-remitting Multiple Sclerosis (RRMS) (CLARITY)

A Safety and Efficacy Study of Oral Cladribine in Subjects With Relapsing-remitting Multiple Sclerosis (RRMS) (CLARITY)

2 mins

Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic Migraine

Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic Migraine

2 mins

Study to Evaluate Oral BIIB061 Added to Interferon-beta1 (IFN-β1) in Relapsing Multiple Sclerosis (RMS)

Study to Evaluate Oral BIIB061 Added to Interferon-beta1 (IFN-β1) in Relapsing Multiple Sclerosis (RMS)

3 mins

Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated With Ozanimod (RPC-1063) (ENLIGHTEN)

Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated With Ozanimod (RPC-1063) (ENLIGHTEN)

3 mins

Impact of Bosutinib on Safety, Tolerability, Biomarkers and Clinical Outcomes in Dementia With Lewy Bodies

Impact of Bosutinib on Safety, Tolerability, Biomarkers and Clinical Outcomes in Dementia With Lewy Bodies

4 mins